Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Exact Sciences Corp EXAS

Exact Sciences Corporation is a global advanced cancer diagnostics company. The Company provides a portfolio of products for earlier cancer detection and treatment guidance. Its products and services focus on screening and precision oncology tests. The Company is focusing its research and development efforts on three main areas: Colorectal Cancer Screening, MCED Test Development and MRD Test... see more

Recent & Breaking News (NDAQ:EXAS)

Exact Sciences Announces Agreement to Sell 4,000,000 Common Shares

Business Wire December 15, 2014

Exact Sciences Announces Mercy Hospital St. Louis Now Offering Cologuard®

Business Wire December 2, 2014

Exact Sciences Announces Final Payment Decision for Cologuard® from the Centers for Medicare & Medicaid Services

Business Wire November 25, 2014

Cologuard® Wins Popular Science Magazine's 2014 "Best of What's New" Award

Business Wire November 12, 2014

American Cancer Society Includes Exact Sciences' Cologuard in Colorectal Cancer Prevention and Early Detection Guidelines

Business Wire November 6, 2014

Exact Sciences to Participate in November Conferences

Business Wire November 5, 2014

Exact Sciences Announces Meriter-UnityPoint Health Now Offering Cologuard®

Business Wire October 29, 2014

Exact Sciences Reports Third-Quarter 2014 Financial Results

Business Wire October 27, 2014

Exact Sciences Announces MDVIP As The First Network of Personalized Healthcare Physicians To Offer Cologuard, A New Noninvasive Stool-Based DNA Test For Colon Cancer

Business Wire October 22, 2014

MDVIP Is The First Network of Personalized Healthcare Physicians To Offer Cologuard, A New Noninvasive Stool-Based DNA Test For Colon Cancer

Business Wire October 22, 2014

Exact Sciences to Host Third-Quarter 2014 Results Webcast and Call

Business Wire October 20, 2014

CEO Kevin T. Conroy of Exact Sciences to Be Interviewed Live on Clear Channel -- iHeart Business Talk Radio -- October 16, 2014

Marketwired October 15, 2014

Exact Sciences Announces Final National Coverage Determination for Cologuard®

Business Wire October 9, 2014

Exact Sciences Announces Group Health Cooperative as First Health Plan in Wisconsin to Cover Cologuard®

Business Wire September 22, 2014

Exact Sciences to participate in Baird's 2014 Health Care Conference

Business Wire August 28, 2014

Exact Sciences Announces Mayo Clinic as First Healthcare System to Offer Cologuard®

Business Wire August 25, 2014

FDA Approves Exact Sciences' Cologuard®; First and Only Stool DNA Noninvasive Colorectal Cancer Screening Test

PR Newswire August 12, 2014

Exact Sciences to Participate in Canaccord Genuity Growth Conference

Business Wire August 7, 2014

Doyle, Arora elected; Sterling reelected to Exact Sciences' board of directors

Business Wire July 24, 2014

Exact Sciences Reports Second-Quarter 2014 Financial Results

Business Wire July 22, 2014